The use of any medications during pregnancy should be agreed with a doctor. This rule applies to traditional medicine products and preparations based on natural ingredients. Some women use NovoPassit during pregnancy to improve sleep, improve their mood, and relieve anxiety. Many of them do this without first obtaining a doctor's permission, which can lead to serious negative consequences. Despite the plant origin of the components, the drug is characterized by a high intensity of action. In some cases, during pregnancy, this can cause more harm to the body of the expectant mother and child than good.
In some cases, during pregnancy, the drug can cause more harm to the body of the expectant mother and child than good.
Possibility of use during pregnancy
Pregnant women are allowed to take only those drugs that have undergone clinical trials and received safety categories A, B, or, in extreme cases, C. Novo-Passit has not undergone relevant clinical trials. This means that by default it is not recommended for pregnant women to take Novo-Passit.
However, based on the known influence of the components of novo-passit, some rules have been drawn up that allow or prohibit the use of the medication. Pregnant women often need to take sedatives. Most often due to mood swings, insomnia, irritability. Therefore, there are some reservations in the prohibition of taking Novo-Passit. There are categories of pregnant women who are strictly contraindicated to take Novo-Passit and categories who can drink it, but only if it is really necessary for the expectant mother.
Terms and conditions of storage
Store in a place protected from light and moisture, at temperatures up to 25 °C. Keep away from children.
Shelf life: tablets – 3 years; solution in bottles – 4 years; solution in sachets – 2 years.
Available without a prescription.
Approximate price of Novo-Passit film-coated tablets, 10 pcs. per package – 210 rubles, 30 pcs. per package – 460 rubles, 60 pcs. per package – 720 rubles; solution for oral administration in bottles of 200 ml - 335 rubles, 100 ml - 308 rubles.
NovoPassit is sold in pharmacies upon presentation of a prescription form.
Tablets and vials should be kept away from light. Temperature range 10-25 degrees.
The tablets remain effective for 36 months, and the syrup for 48.
The use of novo-passit is contraindicated
Novo-Passit should not be taken at the beginning of pregnancy. The first trimester is a strict contraindication to prescribing the drug.
First of all, because the components of this medication can disrupt the development of the fetus. Sedatives negatively affect the development of the nervous system, and it is formed in the early stages.
In addition, Novo-Passit contains the herb St. John's wort, which enhances the contractile activity of the uterus. In the first trimester, this can lead to spontaneous abortion. The effect on the contractile activity of the uterus limits the use of novo-passit in the third trimester of pregnancy. It is strictly contraindicated from 34 weeks of gestation until delivery.
General contraindications also apply to pregnant women: allergic reactions, diseases of certain organs, some mental disorders. During pregnancy, which occurs with any complications, Novo-Passit should also not be taken.
Indications for use
Absolute:
- myasthenia gravis;
- impaired absorption of glucose and galactose, congenital fructose intolerance (for solution);
- children under 12 years of age;
- lactation period;
- individual intolerance to the components of the drug, especially guaifenesin.
Relative (diseases/conditions in the presence of which the use of Novo-Passit requires caution):
- liver diseases;
- epilepsy;
- acute pathologies of the gastrointestinal tract;
- alcoholism;
- brain injury or disease;
- pregnancy.
The use of novo-passit is permissible
In some cases, novo-passit can be prescribed to pregnant women. The instructions for the drug say that use is permissible if the benefit to the mother outweighs the possible risk. For novo-passit, this statement is true in the second trimester of pregnancy. By the 12th week, the main structures of the nervous system have already been formed, so the drug will not have a toxic effect on the fetus.
In addition, at the beginning of the third trimester, novo-passitis also does not pose any threat to the fetus and the pregnant woman. Up to 34 weeks it can be taken as prescribed by a doctor. As a rule, it is during this period that a pregnant woman requires support with sedatives. It is worth noting that expectant mothers can only take the medicine in tablets. Novopassit in the form of syrup contains ethyl alcohol, which is toxic to the fetus at any stage of gestation.
Thus, novo-passit during pregnancy can be taken:
- From 13 to 34 weeks of gestational age;
- During a normal pregnancy;
- Provided there are no other contraindications;
- Only in tablet form;
- Only after consulting a doctor.
Effect on the pregnant woman's body
Despite the natural composition, proven effectiveness and safety of the product, NovoPassit is not the best option for helping pregnant women with these conditions.
Doctors recommend using less aggressive analogues whenever possible during pregnancy.
The use of each of them is previously agreed with the doctor. Ideally, you should limit yourself to breathing exercises, the principles of proper nutrition, walks, herbal decoctions, and adherence to a daily routine.
Possible negative consequences of using NovoPassit during pregnancy:
- pathological decrease in blood pressure due to relaxation of the vascular walls, pronounced sedation;
- increased drowsiness, leading to decreased activity of the pregnant woman. This threatens the development of muscle weakness, which worsens the woman’s general condition and causes complications during childbirth;
- circulatory disorders in the placenta. Most often, this problem becomes a consequence of hypotension. The child’s body stops receiving sufficient oxygen and nutrients from the mother, which slows down its development.
The medicine may cause circulatory problems in the placenta.
During pregnancy, the immune reactivity of the female body increases. Even those patients who previously tolerated NovoPassit well may notice an allergic response to the drug. There is also a possibility that after birth the child will develop an intolerance to the drug or its individual components.
Conditions for using Novo-Passit during breastfeeding
During breastfeeding, drugs that can pass into breast milk are prohibited. Novo-passit is not a homogeneous medicine, so it is difficult to say whether its entire composition can end up in breast milk. What is known is that some herbs actually penetrate into milk. Therefore, it is not recommended to take Novo-Passit during breastfeeding.
All components of the drug are sedative. They can affect the baby through breast milk. At the same time, he will become calm, inhibited and drowsy. The components of novo-passit negatively affect the central nervous system of children, and in infants they can even cause neurological diseases or developmental delays.
For children under 12 years of age, taking Novo-Passit is contraindicated; therefore, it should not enter the child’s body through breast milk.
If the mother needs to take sedatives such as Novo-Passit, breastfeeding should be discontinued. In this case, the child is transferred to artificial formula.
Composition and action
The drug "NovoPassit" contains natural ingredients of plant origin. The volume of excipients is minimal, their presence does not affect the severity of the therapeutic effect, and these components do not affect the body.
The product has pronounced calming properties.
They are achieved through the simultaneous influence of valerian, lemon balm, St. John's wort, hawthorn, passionflower, hops, and black elderberry. Guaifenesin, a chemical compound extracted from the bark of the guaiac tree, has special properties.
The mechanism of action of the drug "NovoPassit":
- launching inhibitory processes in the central nervous system, eliminating nervous tension, emotional overload;
- relaxation of muscle fibers, including those that make up the walls of blood channels. This leads to improved vascular function, a reduction in blood pressure elevated due to stress, and improved blood circulation throughout the body;
- facilitating the process of falling asleep by eliminating intrusive thoughts. This leads to increased duration and quality of sleep;
- reducing the excitability of the nervous system, relieving anxiety, unreasonable fears, nervousness;
- eliminating signs of mild depressive disorders;
- increasing psycho-emotional stability, reducing the intensity of the body’s reaction to stress;
- improvement of heart function;
- reducing the intensity of inflammation and pain in the body.
The drug improves blood circulation throughout the body.
Thanks to these properties, in normal situations and during pregnancy, the drug NovoPassit can reduce emotional excitability and relieve insomnia. The natural medicine acts gently but intensely. With the right approach to therapy, the product can relieve a number of neurological problems. It is effective for neuroses and neurasthenia, vegetative-vascular dysfunction, headaches due to chronic stress or overwork.
Analogs
There are a number of medications that you can take during pregnancy. The risk of undesirable consequences both for the fetus and for the general course of pregnancy will be significantly lower than when taking Novo-Passit.
First of all, such products include monocomponent herbal preparations. For example, valerian, lemon balm, mint, hawthorn. It is recommended to start with a decoction of herbs or adding the listed plants to tea. It is strictly contraindicated to take sedative tinctures during pregnancy and breastfeeding. Approved sedatives can only be taken in tablet form.
In addition to herbal sedatives, there are other approved drugs. For example, magnesium B6. This product contains the element magnesium, which is often lacking in the body of a pregnant woman and a woman who has recently given birth, and the vitamin pyridoxine. The latter not only normalizes the activity of the nervous system, but also treats anemia. Other drugs, like Novo-Passit, should be taken with extreme caution and only after consultation with your doctor.
Side effects during pregnancy
A pregnant woman's body often reacts more strongly to the use of medications than during normal times. Products based on natural ingredients are no exception here. Experts identify dyspeptic disorders as a common negative response to NovoPassit during pregnancy. Patients note the appearance of nausea, heartburn, constipation or diarrhea, and abdominal cramps. Reactions from the nervous system occur slightly less frequently: dizziness, drowsiness, decreased concentration. Sometimes the risks are associated with an allergic response of the body, which may be limited to itching or take the form of unaesthetic skin rashes.
Typically, negative manifestations are mild and temporary. They often go away on their own within a few hours after their occurrence and are not even associated with taking a sedative.
Regardless of the degree of discomfort and its duration, it is recommended to report such moments to your doctor.
Reviews
Arina K .: “During pregnancy, I suffered from insomnia. At first I took valerian, but then it stopped helping. My doctor prescribed Novo-Passit to me when I was about five months pregnant. I took one tablet before bed. The insomnia has passed. I took Novo-Passit for three weeks and then another course in the seventh month. After that I didn't need it anymore. I didn’t observe any side effects.”
Obstetrician-gynecologist : “Pregnant women often ask to be prescribed something sleeping pills or sedatives. Unfortunately, most drugs are contraindicated during pregnancy. There remain various herbal infusions that do not always help and not everyone. We actively prescribe Novo-Passit, but we strictly adhere to the terms under which its use is permissible. As a rule, from 5 to 8 months you can actively use this drug in small dosages.”
Content
special instructions
While taking the medicine, you should not drink alcohol.
For patients receiving Novo-Passit, especially patients with fair skin, it is important to avoid exposure to ultraviolet radiation (visiting a solarium, prolonged exposure to direct sunlight).
If there is no improvement in the condition, an increase in existing symptoms, the development of side effects or other unusual reactions, it is recommended to consult a doctor for advice.
The oral solution contains 12.19% ethanol; in a single dose its content is no more than 0.481 g.
Patients with diabetes mellitus should take into account that 100 g of solution contains fructose (13.6–15.3 g) and glucose (12.5–14.2 g). When taking recommended doses, each dose contains no more than 1.53 g of fructose and 1.42 g of glucose.
During the treatment period, patients should refrain from driving vehicles and engaging in potentially hazardous activities.
It is unacceptable to drink alcohol while taking NovoPassit.
In case of acute pathology of the digestive tract, the medication is prescribed with caution. Doctors should inform patients that if within 7 days the patient’s condition not only does not improve, but also worsens, then a doctor’s consultation is required.
Patients with fair skin are advised to avoid exposure to direct sunlight and refrain from visiting a solarium.
The medicine in the form of syrup is not prescribed for fructose intolerance (congenital characteristic), or for impaired absorption of galactose/glucose.
The syrup contains alcohol (12.19% ethanol). A single dose contains 0.481 grams of ethanol. Considering the characteristics of the medication, it is not recommended to drive vehicles or complex machinery during a course of taking a sedative.
The composition of the tablet form and the oral solution is absolutely identical. The tablets are easy to use - you can take them with you, but the syrup is easier to dose in pediatric practice.
Let's get acquainted with the drug
"Novo-Passit" is a modern combined drug that exhibits sedative and anxiolytic effects. Its peculiarity lies in its powerful herbal composition, enhanced by a natural anxiolytic. Careful selection of herbs allows you to fight various forms of nervous disorders and eliminate psycho-emotional stress in the shortest possible time. For pregnant women, the drug can be prescribed for systematic or situational use.
Indications for use
The complex sedative effect of the drug is appropriate for the treatment of the following conditions in pregnant women:
- mild forms of neuroses;
- neurasthenic states with sadness, fear, anxiety;
- mild memory disorders;
- complex therapy of migraine and headaches;
- diseases of the digestive system of neurogenic nature;
- skin pathologies due to nervous tension (atopic dermatitis, eczema, urticaria).
The content of plants that exhibit antidepressant effects helps fight chronic fatigue syndrome, loss of strength that occurs against the background of nervous disorders and anxiety.
Indications for use include neurogenic insomnia, difficulty falling asleep, mild memory disorders, absent-mindedness, and difficulty concentrating. "Novo-Passit" during pregnancy will help to cope with typical manifestations of emotional lability that accompany active hormonal changes in the body of the expectant mother.
Composition and action
The main pharmacological activity is manifested through a combination of seven different medicinal plants that have a sedative effect.
- Valerian extract. It has sedative and vasodilating properties. It works due to the content of special alkaloids and essential oils. It is the “gold” standard for the treatment of neurasthenic disorders during pregnancy.
- Melissa extract. It has a calming effect with a slight tonic and antidepressant effect. Eliminates chronic fatigue syndrome, apathy, increases performance. Has antispasmodic activity.
- St. John's wort extract. It is used as a natural antidepressant that can eliminate anxiety, fears, loss of strength, and apathy. The plant normalizes the process of falling asleep, eliminates insomnia, improves mood and stress resistance of the body.
- Hawthorn extract. It has antihypertensive properties, eliminates heart rhythm disturbances caused by stressful situations. Helps improve myocardial function by enhancing heart contractions, slightly increasing their amplitude, ensuring normal blood supply to prevent ischemia.
- Passionflower extract. Has a mild hypnotic effect. Eliminates anxiety, facilitates falling asleep, relieves spasms of smooth muscles. Improves heart function, normalizes biorhythms.
- Hops extract. It has calming properties, makes sleep deeper, and the process of waking up easier. It has a positive effect on the functioning of the cardiovascular system and eliminates tachycardia. Contains phytoestrogens.
- Elderberry extract. It has antispasmodic and anti-inflammatory properties. Has a diuretic effect.
The herbal composition enhances the anxiolytic of natural origin - guaifenesin. This substance has antispasmodic and moderate sedative properties, helps fight fear, anxiety, sleep disorders, eliminate depression and bad mood.
Effect on the pregnant woman's body
The pronounced sedative effect of the drug helps to cope not only with nervous disorders, but also with digestive disorders and skin problems that arise from them. The mutually potentiating effect of plants helps improve the functioning of the heart muscle, which is very appropriate when the load increases during the period of bearing a child.
Several plants and guaifenesin have an effect on smooth muscle tone, reducing it. This property can have a positive effect on the course of pregnancy, accompanied by myometrial hypertonicity.
Release forms of the drug
Novo-Passit is available in two dosage forms: tablets and solution. Dry plant extracts and guaifenesin are used to make tablets. As well as tablet formers, ensuring the stability of the dosage form. In addition, the tablets are coated with an enteric coating that protects the stomach walls from irritation.
The Novo-Passit solution (popularly the name of the form is confused with syrup) is a brown liquid with a pronounced specific odor and bitter taste. Contains ethanol. One dose of the drug contains about 480 mg of pure alcohol, which may be undesirable during pregnancy.
Release form
The release form of novopassit is presented in two versions - in the form of a solution and as tablets.
The solution, intended for oral administration, has the appearance of a clear or somewhat cloudy liquid with a consistency similar to syrup. The color of the solution is brown, or red with a brown tint. Has a specific smell. The drug in the form of a solution in an amount of 100 or 200 milliliters, respectively, is contained in a dark glass bottle with a screw cap. The cap serves as a measuring container for convenient dosing of the drug. The bottle has a glued label, which also contains instructions for use folded inside. The bottle is placed in a cardboard box. After some storage time, a small amount of sediment may form in the solution. Its presence is acceptable and when shaken it dissolves.
